These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 23666920)

  • 41. Sulforaphane enhances progerin clearance in Hutchinson-Gilford progeria fibroblasts.
    Gabriel D; Roedl D; Gordon LB; Djabali K
    Aging Cell; 2015 Feb; 14(1):78-91. PubMed ID: 25510262
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hutchinson-Gilford progeria syndrome through the lens of transcription.
    Prokocimer M; Barkan R; Gruenbaum Y
    Aging Cell; 2013 Aug; 12(4):533-43. PubMed ID: 23496208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abolishing the prelamin A ZMPSTE24 cleavage site leads to progeroid phenotypes with near-normal longevity in mice.
    Wang Y; Shilagardi K; Hsu T; Odinammadu KO; Maruyama T; Wu W; Lin CS; Damoci CB; Spear ED; Shin JY; Hsu W; Michaelis S; Worman HJ
    Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35197292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hutchinson-Gilford Progeria Syndrome: A Premature Aging Disease.
    Ahmed MS; Ikram S; Bibi N; Mir A
    Mol Neurobiol; 2018 May; 55(5):4417-4427. PubMed ID: 28660486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model.
    Capell BC; Olive M; Erdos MR; Cao K; Faddah DA; Tavarez UL; Conneely KN; Qu X; San H; Ganesh SK; Chen X; Avallone H; Kolodgie FD; Virmani R; Nabel EG; Collins FS
    Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15902-7. PubMed ID: 18838683
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Compound heterozygosity for mutations in LMNA causes a progeria syndrome without prelamin A accumulation.
    Verstraeten VL; Broers JL; van Steensel MA; Zinn-Justin S; Ramaekers FC; Steijlen PM; Kamps M; Kuijpers HJ; Merckx D; Smeets HJ; Hennekam RC; Marcelis CL; van den Wijngaard A
    Hum Mol Genet; 2006 Aug; 15(16):2509-22. PubMed ID: 16825282
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Premature Vascular Aging with Features of Plaque Vulnerability in an Atheroprone Mouse Model of Hutchinson-Gilford Progeria Syndrome with
    Nevado RM; Hamczyk MR; Gonzalo P; Andrés-Manzano MJ; Andrés V
    Cells; 2020 Oct; 9(10):. PubMed ID: 33049978
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice.
    Koblan LW; Erdos MR; Wilson C; Cabral WA; Levy JM; Xiong ZM; Tavarez UL; Davison LM; Gete YG; Mao X; Newby GA; Doherty SP; Narisu N; Sheng Q; Krilow C; Lin CY; Gordon LB; Cao K; Collins FS; Brown JD; Liu DR
    Nature; 2021 Jan; 589(7843):608-614. PubMed ID: 33408413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discordant gene expression signatures and related phenotypic differences in lamin A- and A/C-related Hutchinson-Gilford progeria syndrome (HGPS).
    Plasilova M; Chattopadhyay C; Ghosh A; Wenzel F; Demougin P; Noppen C; Schaub N; Szinnai G; Terracciano L; Heinimann K
    PLoS One; 2011; 6(6):e21433. PubMed ID: 21738662
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel somatic mutation achieves partial rescue in a child with Hutchinson-Gilford progeria syndrome.
    Bar DZ; Arlt MF; Brazier JF; Norris WE; Campbell SE; Chines P; Larrieu D; Jackson SP; Collins FS; Glover TW; Gordon LB
    J Med Genet; 2017 Mar; 54(3):212-216. PubMed ID: 27920058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation.
    Yang SH; Bergo MO; Toth JI; Qiao X; Hu Y; Sandoval S; Meta M; Bendale P; Gelb MH; Young SG; Fong LG
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10291-6. PubMed ID: 16014412
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LMNA mutations in progeroid syndromes.
    Huang S; Kennedy BK; Oshima J
    Novartis Found Symp; 2005; 264():197-202; discussion 202-7, 227-30. PubMed ID: 15773755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice.
    Fong LG; Ng JK; Meta M; Coté N; Yang SH; Stewart CL; Sullivan T; Burghardt A; Majumdar S; Reue K; Bergo MO; Young SG
    Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18111-6. PubMed ID: 15608054
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased progerin expression associated with unusual LMNA mutations causes severe progeroid syndromes.
    Moulson CL; Fong LG; Gardner JM; Farber EA; Go G; Passariello A; Grange DK; Young SG; Miner JH
    Hum Mutat; 2007 Sep; 28(9):882-9. PubMed ID: 17469202
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disruption of lamin B1 and lamin B2 processing and localization by farnesyltransferase inhibitors.
    Adam SA; Butin-Israeli V; Cleland MM; Shimi T; Goldman RD
    Nucleus; 2013; 4(2):142-50. PubMed ID: 23475125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aging: progeria and the lamin connection.
    Kudlow BA; Kennedy BK
    Curr Biol; 2006 Aug; 16(16):R652-4. PubMed ID: 16920618
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hutchinson-Gilford Progeria Syndrome (Hgps) and Application of Gene Therapy Based Crispr/Cas Technology as A Promising Innovative Treatment Approach.
    Rajeev M; Ratan C; Krishnan K; Vijayan M
    Recent Pat Biotechnol; 2021; 15(4):266-285. PubMed ID: 34602042
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes.
    Toth JI; Yang SH; Qiao X; Beigneux AP; Gelb MH; Moulson CL; Miner JH; Young SG; Fong LG
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12873-8. PubMed ID: 16129834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LMNA is mutated in Hutchinson-Gilford progeria (MIM 176670) but not in Wiedemann-Rautenstrauch progeroid syndrome (MIM 264090).
    Cao H; Hegele RA
    J Hum Genet; 2003; 48(5):271-274. PubMed ID: 12768443
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.